QT Imaging
About: QT Imaging Holdings Inc is engaged in the research, development and commercialization of an automated breast imaging system producing high-resolution transmission ultrasound images.
Employees: 3
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
113% more capital invested
Capital invested by funds: $1.16M [Q2] → $2.47M (+$1.31M) [Q3]
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
19% more funds holding
Funds holding: 16 [Q2] → 19 (+3) [Q3]
8.92% more ownership
Funds ownership: 7.34% [Q2] → 16.26% (+8.92%) [Q3]
Research analyst outlook
We haven’t received any recent analyst ratings for QTI.
Financial journalist opinion
Neutral
Business Wire
1 week ago
QT Imaging Holdings Announces New Commercial Shipment in Partnership with Couri Center
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems is pleased to announce expansion of locations offering the Breast Acoustic CTTM Scanner to Couri Center for Gynecology and Integrative Women's Health, in Peoria, IL. The shipment was made together with our strategic business and distribution partner, NXC Imaging, Inc. "Our partnership with QTI marks a pivotal.
Neutral
Business Wire
4 weeks ago
QT Imaging Holdings to Attend Radiological Society of North America 2024 Annual Meeting
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce participation at the Radiological Society of North America 2024 Annual Meeting, taking place in Chicago, December 1-5, 2024. Dr. Bilal Malik, Chief Science Officer, Dr. James Wiskin, Fellow, and Dr. Raluca Dinu, Chief Executive Officer, will represent QTI at the event. Dr. Bilal Malik w.
Neutral
Business Wire
1 month ago
QT Imaging Announces Third Quarter 2024 Financial Results
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the third quarter of 2024. “During this quarter, QT Imaging's team successfully completed the engineering and clinical feasibility study with our strategic partner and shipped two QT Breast Acoustic CT™ Scanners to a nationally recognized.
Neutral
Business Wire
1 month ago
QT Imaging Holdings Announces $1M Insiders PIPE Investment
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems (the “Company” or “QTI”) is pleased to announce an insiders private investment in public equities (PIPE) investment of $1.0 million in new funding, led by the Chairman of the Board, Dr. Avi Katz, and the Chief Executive Officer, Dr. Raluca Dinu, with participation of an additional four QTI Board of Directors m.
Neutral
Business Wire
1 month ago
QT Imaging Granted Renewal of NIH Sponsored Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the third year renewal of its five-year research grant from the National Institutes of Health (NIH)/National Cancer Institute (NCI). The study is a collaboration with the Department of Radiation Oncology, the Radiation Treatment Program at the Sunnybrook Health Sciences Centre in Toront.
Neutral
Business Wire
2 months ago
QT Imaging Holdings Announces Favorable Amendment of Convertible Promissory Note
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce an amendment to its $10,000,000 convertible promissory note with YA II PN, Ltd. (the “Investor,” and such promissory note, the “Note”). On September 11, 2024, a trigger event associated with the share price of the company occurred under the terms of the Note. As a result, the company m.
Neutral
Business Wire
3 months ago
QT Imaging Holdings Announces Participation in the IEEE International Ultrasonics Symposium, in Taipei, Taiwan
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce participation in the International Ultrasonics Symposium (IUS), an IEEE Ultrasonics, Ferroelectrics, and Frequency Control Society conference, held in Taipei, Taiwan, on September 22-26, 2024. Dr. James Wiskin will represent QTI in the Medical Imaging subsection. The presentation focuss.
Neutral
Business Wire
3 months ago
QT Imaging Holdings Announces Further Expansion of Locations Offering Its Technology at Vitality Renewal, in Illinois
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce further expansion of locations offering the Breast Acoustic CT™ Scanner to Vitality Renewal Functional Medicine, in Crystal Lake, Illinois. The commercial shipment was made together with our strategic business and distribution partner. Dr. Yvonne Karney, founder of Vitality Renewal Func.
Neutral
InvestorPlace
3 months ago
QTI Stock Earnings: QT Imaging Holdings Reported Results for Q2 2024
QT Imaging Holdings (NASDAQ: QTI ) just reported results for the second quarter of 2024. QT Imaging Holdings reported earnings per share of -30 cents.
Neutral
Business Wire
4 months ago
QT Imaging Announces Second Quarter 2024 Financial Results
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the second quarter of 2024. “QT Imaging's team completed the first full quarter in the life of our young public company. We continued to deliver against our plan for the engineering and clinical feasibility study to solidify the intended.
Charts implemented using Lightweight Charts™